SEPN1: Associated with congenital fiber-type disproportion and insulin resistance

Objective Our first objective was to determine whether SEPN1 gene mutations are a cause of congenital fiber‐type disproportion (CFTD), a rare form of congenital myopathy in which relative hypotrophy of type 1 (slow twitch) muscle fibers is the principal abnormality on histology. Second, we investiga...

Full description

Saved in:
Bibliographic Details
Published in:Annals of neurology Vol. 59; no. 3; pp. 546 - 552
Main Authors: Clarke, Nigel F., Kidson, Warren, Quijano-Roy, Susana, Estournet, Brigitte, Ferreiro, Ana, Guicheney, Pascale, Manson, James I., Kornberg, Andrew J., Shield, Lloyd K., North, Kathryn N.
Format: Journal Article
Language:English
Published: Hoboken Wiley Subscription Services, Inc., A Wiley Company 01-03-2006
Willey-Liss
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective Our first objective was to determine whether SEPN1 gene mutations are a cause of congenital fiber‐type disproportion (CFTD), a rare form of congenital myopathy in which relative hypotrophy of type 1 (slow twitch) muscle fibers is the principal abnormality on histology. Second, we investigated an association between SEPN1‐related myopathy and insulin resistance. Methods We sequenced SEPN1 in five unrelated CFTD patients with scoliosis and respiratory muscle weakness and screened an additional 22 CFTD patients for abnormalities in SEPN1 by Western blotting and restriction digest for the 943G→A mutation. We performed oral glucose tolerance tests (OGTTs) in eight SEPN1‐related myopathy patients. Results Two sisters with CFTD were homozygous for the 943G→A SEPN1 mutation and had clinical features typical of previously reported patients with SEPN1‐related myopathy. Five of eight SEPN1‐related myopathy patients had abnormalities on OGTT suggestive of insulin resistance. Interpretation SEPN1 is the second genetic cause of CFTD and the first cause of autosomal recessive CFTD to be identified to our knowledge. CFTD is the fourth clinicopathological presentation that can be associated with mutations in SEPN1. Insulin resistance may be a specific, previously unrecognized aspect of SEPN1‐related myopathy. Ann Neurol 2006
Bibliography:Muscular Dystrophy Association of New South Wales, Australia
National Health and Medical Research Council of Australia - No. 139039; No. 206529
istex:BB957079C5102318712D56E6CC10E28C18BC6CAA
ArticleID:ANA20761
ark:/67375/WNG-G4HHVN3S-G
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0364-5134
1531-8249
DOI:10.1002/ana.20761